Cargando…

Optimization of Q.Clear reconstruction for dynamic (18)F PET imaging

BACKGROUND: Q.Clear, a Bayesian penalized likelihood reconstruction algorithm, has shown high potential in improving quantitation accuracy in PET systems. The Q.Clear algorithm controls noise during the iterative reconstruction through a β penalization factor. This study aimed to determine the optim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lysvik, Elisabeth Kirkeby, Mikalsen, Lars Tore Gyland, Rootwelt-Revheim, Mona-Elisabeth, Emblem, Kyrre Eeg, Hjørnevik, Trine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589167/ https://www.ncbi.nlm.nih.gov/pubmed/37861929 http://dx.doi.org/10.1186/s40658-023-00584-1

Ejemplares similares

The effect of Q.Clear reconstruction on quantification and spatial resolution of 18F-FDG PET in simultaneous PET/MR
por: Tian, Defeng, et al.
Publicado: (2022)

Impact of the Q.Clear reconstruction algorithm on the interpretation of PET/CT images in patients with lymphoma
por: Wyrzykowski, Michał, et al.
Publicado: (2020)

Performance evaluation of the Q.Clear reconstruction framework versus conventional reconstruction algorithms for quantitative brain PET-MR studies
por: Ribeiro, Daniela, et al.
Publicado: (2021)

Bayesian penalised likelihood reconstruction (Q.Clear) of (18)F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation
por: Teoh, Eugene J, et al.
Publicado: (2018)

Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images
por: Texte, Edgar, et al.
Publicado: (2020)

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

Impact of γ factor in the penalty function of Bayesian penalized likelihood reconstruction (Q.Clear) to achieve high-resolution PET images
por: Miwa, Kenta, et al.
Publicado: (2023)

Impact of the Noise Penalty Factor on Quantification in Bayesian Penalized Likelihood (Q.Clear) Reconstructions of (68)Ga-PSMA PET/CT Scans
por: Rijnsdorp, Sjoerd, et al.
Publicado: (2021)

Phantom and clinical assessment of small pulmonary nodules using Q.Clear reconstruction on a silicon-photomultiplier-based time-of-flight PET/CT system
por: Wu, Zhifang, et al.
Publicado: (2021)

Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)
por: Rogasch, Julian M., et al.
Publicado: (2020)

Assessing the impact of different penalty factors of the Bayesian reconstruction algorithm Q.Clear on in vivo low count kinetic analysis of [(11)C]PHNO brain PET-MR studies
por: Ribeiro, Daniela, et al.
Publicado: (2022)

Optimization of a Bayesian penalized likelihood algorithm (Q.Clear) for (18)F-NaF bone PET/CT images acquired over shorter durations using a custom-designed phantom
por: Yoshii, Tokiya, et al.
Publicado: (2020)

The effects of various penalty parameter values in Q.Clear algorithm for rectal cancer detection on (18)F-FDG images using a BGO-based PET/CT scanner: a phantom and clinical study
por: Sadeghi, Fatemeh, et al.
Publicado: (2023)

Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2023)

Correction: Rijnsdorp et al. Impact of the Noise Penalty Factor on Quantification in Bayesian Penalized Likelihood (Q.Clear) Reconstructions of (68)Ga-PSMA PET/CT Scans. Diagnostics 2021, 11, 847
por: Rijnsdorp, Sjoerd, et al.
Publicado: (2021)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

Inter-reader agreement of (18)F-FDG PET/CT for the quantification of carotid artery plaque inflammation
por: Johnsrud, Kjersti, et al.
Publicado: (2020)

(18)F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
por: Johnsrud, Kjersti, et al.
Publicado: (2017)

MR elastography identifies regions of extracellular matrix reorganization associated with shorter survival in glioblastoma patients
por: Svensson, Siri Fløgstad, et al.
Publicado: (2023)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

(18)F-FDG and (18)F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
por: Reddy, Natasha, et al.
Publicado: (2023)

Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2010)

Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes
por: Eide, Per Kristian, et al.
Publicado: (2018)

The role of (18)F-FDG PET/CT in primary cutaneous lymphoma: an educational review
por: McDonald, Elysia O., et al.
Publicado: (2023)

The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19
por: Griffin, Matthew T., et al.
Publicado: (2023)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

(18)F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
por: Mouminah, Alaa, et al.
Publicado: (2020)

The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2013)

Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
por: Alavi, Abass, et al.
Publicado: (2022)

Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
por: Nilsen, Line Brennhaug, et al.
Publicado: (2020)

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
por: Müller, Ebba Gløersen, et al.
Publicado: (2019)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
por: Helgebostad, Rasmus, et al.
Publicado: (2022)

PET-Based Imaging with (18)F-FDG and (18)F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
por: Raynor, William Y., et al.
Publicado: (2021)

Non-invasive assessment of pulsatile intracranial pressure with phase-contrast magnetic resonance imaging
por: Ringstad, Geir, et al.
Publicado: (2017)

NaF-PET Imaging of Atherosclerosis Burden
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Emerging role of 18F-FDG PET/CT in Castleman disease: a review
por: Koa, Benjamin, et al.
Publicado: (2021)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Neurological and Psychiatric Manifestations of Long COVID-19 and Their [(18)F]FDG PET Findings: A Review
por: Hameed, Rizwanullah, et al.
Publicado: (2023)

Aging and Cerebral Glucose Metabolism: (18)F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
por: Subtirelu, Robert Christopher, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8oonq4bfsd74jo5or858h7v1qj